Categories Earnings, IPO, Technology

Weak Macros drag Western Digital’s Q2 earnings

Data storage provider Western Digital (NASDAQ: WDC) reported weaker-than-expected Q2 results. The company continues to be impacted by falling NAND flash prices caused by muted demand coupled with abundant supply resulting in lower average selling prices (ASP) per gigabyte which impacts the top line.

The company’s Q2 revenues dwindled 20.6% to $4.2 billion hurt by lower demand from its clients across all its divisions. Adjusted earnings came in at $1.45 per share failing to meet analyst estimates.

Last quarter, the company expected Q2 revenues to be between $4.2 billion and $4.4 billion and adjusted earnings in the range of $1.45 to $1.65 per share. Despite failing to meet street estimates, Western Digital’s results were in line with its Q2 outlook provided last quarter.

Analysts expected Western Digital’s adjusted EPS to come in at $1.49 and revenue of $4.25 billion taking into account the tough macro headwinds faced by the firm. It’s worth noting that for the corresponding period last year, revenue was $5.34 billion with earnings of $3.95 per share aided by income tax benefits.

From an end market perspective, Client Devices reported a 16.4% dip in revenues over last year due to weak demand and falling flash prices in the mobility and embedded applications. Client Solutions revenue was down nearly 25% due to softening demand and pricing pressure on flash and HDD products. Reduced cloud spending from its clients resulted in Data Center Devices and Solutions revenue decreasing by 25% in the second quarter.

One of the primary concerns for investors is Western Digital’s free cash flow. The company reported $24 million as free cash flow, which is a sharp drop of 96% over last year. Last quarter, the company reported $457 million as free cash flow.

Demand for flash-based products has been plateauing due to the emergence of new technologies, increased supply resulting in higher inventories for companies like Western Digital. Adding fuel to the fire, the trade war between the US and China has made things worse with the steady fall of NAND flash prices. This has forced Western Digital to scale back flash production for 2019 by 10% to 15% in Flash Ventures. This would help the firm to recalibrate production in line with market demand which would result in lower inventories.

Related: Western Digital Q1 2019 earnings call transcript

Flash Ventures is a joint venture (JV) with Toshiba Memory Corporation (TMC) to produce flash-based products through the Yokkaichi (Japan) facility. It’s mandatory for Western Digital to pay 50% of fixed costs incurred by the JV regardless of whether the company buys flash-related offerings from Flash Ventures. The company expects to record $250 million to $300 million as charges relating to reduced production from Flash Ventures.

Last quarter, 48% of the top line contribution came from its top 10 customers and the top two alone contributed 11% to revenues. It’s important for the company to reduce its dependency on revenues from the top 10 clients and needs to broaden its customer base.

Apart from Western Digital, chipmaker Intel also reported its Q4 earnings. Intel Corporation (INTC) reported mixed results in the quarter with EPS coming in at $1.28 on revenue of $18.7 billion. Analysts expected the company to post earnings of $1.22 per share on revenue of $19.01 billion. The company’s stock was down about 7% after the bell.

Western Digital’s stock price plummeted more than 50% over the last 12 months due to multiple headwinds faced by the firm has worried investors. The stock price hit a new 52-week low level in December touching $33.83 levels. It has recovered about 9% in 2019 and is trading at $39 range during the extended hours of trading.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top